Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Invested Capital (2016 - 2025)

Xtant Medical Holdings has reported Invested Capital over the past 16 years, most recently at $62.0 million for Q4 2025.

  • Quarterly Invested Capital fell 4.65% to $62.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.0 million through Dec 2025, down 4.65% year-over-year, with the annual reading at $62.0 million for FY2025, 4.65% down from the prior year.
  • Invested Capital was $62.0 million for Q4 2025 at Xtant Medical Holdings, roughly flat from $61.7 million in the prior quarter.
  • Over five years, Invested Capital peaked at $65.0 million in Q4 2024 and troughed at $31.9 million in Q2 2022.
  • The 5-year median for Invested Capital is $47.9 million (2023), against an average of $47.6 million.
  • The largest YoY upside for Invested Capital was 181.01% in 2021 against a maximum downside of 24.71% in 2021.
  • A 5-year view of Invested Capital shows it stood at $34.5 million in 2021, then grew by 27.11% to $43.9 million in 2022, then rose by 27.62% to $56.0 million in 2023, then increased by 16.13% to $65.0 million in 2024, then decreased by 4.65% to $62.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Invested Capital are $62.0 million (Q4 2025), $61.7 million (Q3 2025), and $60.5 million (Q2 2025).